Improving prognosis of glioblastoma in the 21st century: Who has benefited most?

Cancer

Volumn 118, Issue 17, 2012, Pages 4228-4234

  Lawrence, Yaacov Richard ^a,b   Mishra, Mark V ^b   Werner Wasik, Maria ^b   Andrews, David W ^b   Showalter, Timothy N ^b   Glass, Jon ^b   Shen, Xinglei ^b   Symon, Zvi ^a   Dicker, Adam P ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

elderly; glioblastoma; glioma; health disparities; radiation treatment; temozolomide

Indexed keywords

TEMOZOLOMIDE;

ADULT; AGED; ARTICLE; BRAIN SURGERY; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURVIVAL; FEMALE; GLIOBLASTOMA; HEALTH CARE QUALITY; HEALTH DISPARITY; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; SOCIAL STATUS; SURVIVAL TIME; TOTAL QUALITY MANAGEMENT;

AGE FACTORS; AGED; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; GLIOBLASTOMA; HUMANS; INCOME; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PROGNOSIS; SURVIVAL ANALYSIS; TIME FACTORS; YOUNG ADULT;

EID: 84865326560     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.26685     Document Type: Article

References (9)

1. Ohgaki H, Kleihues P,. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol. 2005; 64: 479-489.
2. Stupp R, Mason WP, van den Bent MJ, et al. European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005; 352: 987-996.
3. Linz U,. Commentary on Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial (Lancet Oncol. 2009;10:459-466). Cancer. 2010; 116: 1844-1846.
4. Yu JB, Gross CP, Wilson LD, Smith BD,. NCI SEER public-use data: applications and limitations in oncology research. Oncology (Williston Park). 2009; 23: 288-295.
5. Grossman SA, Ye X, Piantadosi S, et al. NABTT CNS Consortium. Survival of patients with newly diagnosed glioblastoma treated with radiation and temozolomide in research studies in the United States. Clin Cancer Res. 2010; 16: 2443-2449.
6. Curran WJ Jr, Scott CB, Horton J, et al. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst. 1993; 85: 704-710.
7. Keime-Guibert F, Chinot O, Taillandier L, et al. Association of French-Speaking Neuro-oncologists. Radiotherapy for glioblastoma in the elderly. N Engl J Med. 2007; 356: 1527-1535.
8. Fine HA, Dear KB, Loeffler JS, Black PM, Canellos GP,. Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer. 1993; 71: 2585-2597.
9. Iwamoto FM, Cooper AR, Reiner AS, Nayak L, Abrey LE,. Glioblastoma in the elderly: the Memorial Sloan-Kettering Cancer Center Experience (1997-2007). Cancer. 2009; 115: 3758-3766.